Exact Mass: 328.297729

Exact Mass Matches: 328.297729

Found 240 metabolites which its exact mass value is equals to given mass value 328.297729, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Stanozolol

1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-Trimethyl-cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol

C21H32N2O (328.25145019999997)


Stanozolol is only found in individuals that have used or taken this drug. Stanozolol has is a synthetic anabolic steroid with therapeutic uses in treating hereditary angioedema. Stanozolol was first synthesized by Clinton et al. in 1959, as a heterocyclic anabolic androgenic steroid. The structure of Stanozolol differs from endogenous steroid hormones and most commercially available anabolic steroids. It most closely resembles methyl testosterone. Instead of the 3-ketogroup in methyltestosterone, there is a pyrazole ring fused to the androstane ring system. This slightly different structure has the disadvantage of making extraction and isolation of the molecule from matrices more difficult. Like most other anabolic steroids, Stanozolol has poor gas chromatographic behavior and is difficult to detect in urine, because of renal clearance and low urinary excretion. This is due to the rapid metabolization, leading to low concentration levels of the parent compound found in urine. Therefore, most research studies had focused on the detection of urinary metabolites. Androgens are drugs, derived from the natural male sex hormone testosterone, with high anabolic potential and minimized androgenic activity. It has been abused by several high profile professional athletes. Stanozolol binds to androgen receptors, such as membrane bound receptor proteins LAGS and stanozolol-binding protein (STBP). Anabolic steroids stimulate protein synthesis, resulting in an acceleration of the food conversion rate and increasing muscle growth, body mass and enhanced performance. Androgens can be used as therapeutics, because they accelerate the recovery of protein deficiency and protein-wasting disorders (e.g. osteoporosis), but they are also widely abused in doping, as well in animals as in men. (PMID: 10404632, 10435307, 11175645, 11284331, 12064656, 12580506, 1448813, 14698206, 15013688, 15458725, 15631866, 15664350, 16040239, 16259046, 16288903, 1640693, 17066372, 17146762, 2306548, 2362445, 2625454, 2663904, 6539197, 9001957, 9300863, 9580049). Stanozolol was first synthesized by Clinton et al. in 1959, as a heterocyclic anabolic androgenic steroid. The structure of Stan differs from endogenous steroid hormones and most commercially available anabolic steroids. It most closely resembles methyl testosterone. Instead of the 3-ketogroup in methyltestosterone, there is a pyrazole ring fused to the androstane ring system. This slightly different structure has the disadvantage of making extraction and isolation of the molecule from matrices more difficult. Like most other anabolic steroids, Stan has poor gas chromatographic behavior and is difficult to detect in urine, because of renal clearance and low urinary excretion. This is due to the rapid metabolization, leading to low concentration levels of the parent compound found in urine. Therefore, most research studies had focused on the detection of urinary metabolites. A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid

   

2-hydroxyphytanic acid

(2S)-2-hydroxy-3,7,11,15-tetramethylhexadecanoic acid

C20H40O3 (328.297729)


A methylated long-chain hyroxy fatty acid formed during alpha-oxidation of phytanic acid by liver mitochondria and peroxisomes, but it is detected in tissues only in patients with peroxisomal disorders.

   

Avocadene 4-acetate

1,2-dihydroxyheptadec-16-en-4-yl acetate

C19H36O4 (328.2613456)


Avocadene 4-acetate is found in fruits. Avocadene 4-acetate is a constituent of avocado (Persea americana) Constituent of avocado (Persea americana). Avocadene 4-acetate is found in fruits.

   

Avocadene 1-acetate

2,4-dihydroxyheptadec-16-en-1-yl acetate

C19H36O4 (328.2613456)


Avocadene 1-acetate is found in fruits. Avocadene 1-acetate is a constituent of avocado (Persea americana) Constituent of avocado (Persea americana). Avocadene 1-acetate is found in fruits.

   

3-hydroxyicosanoic Acid

beta-Hydroxyeicosanoic acid

C20H40O3 (328.297729)


3-hydroxyicosanoic Acid is also known as 3-Hydroxyeicosanoate or 3-Hydroxyarachidic acid. 3-hydroxyicosanoic Acid is considered to be practically insoluble (in water) and acidic. 3-hydroxyicosanoic Acid can be synthesized from arachidic acid. 3-hydroxyicosanoic Acid can be synthesized into 3-hydroxyicosanoyl-CoA. 3-hydroxyicosanoic Acid is a fatty acid lipid molecule

   

erythro-6,8-Heneicosanediol

erythro-6,8-Heneicosanediol

C21H44O2 (328.3341124)


erythro-6,8-Heneicosanediol is found in fats and oils. erythro-6,8-Heneicosanediol is a constituent of the dried flowers of Carthamus tinctorius (safflower). Constituent of the dried flowers of Carthamus tinctorius (safflower). erythro-6,8-Heneicosanediol is found in fats and oils and herbs and spices.

   

MG(16:1(9Z)/0:0/0:0)

(2S)-2,3-dihydroxypropyl (9Z)-hexadec-9-enoate

C19H36O4 (328.2613456)


MG(16:1(9Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(16:1(9Z)/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(16:1(9Z)/0:0/0:0) is made up of one 9Z-hexadecenoyl(R1).

   

1,21-Heneicosanediol

henicosane-1,21-diol

C21H44O2 (328.3341124)


1,21-Heneicosanediol is found in pomes. 1,21-Heneicosanediol is a constituent of apple wax Constituent of apple wax. 1,21-Heneicosanediol is found in pomes.

   

2(R)-hydroxyicosanoic acid

alpha-Hydroxyeicosanoic acid

C20H40O3 (328.297729)


2(R)-Hydroxyicosanoic acid is along-chain hydroxy fatty acid. In humans fatty acids are predominantly formed in the liver and adipose tissue, and mammary glands during lactation.

   

MG(0:0/16:1(9Z)/0:0)

1,3-dihydroxypropan-2-yl (9Z)-hexadec-9-enoate

C19H36O4 (328.2613456)


MG(0:0/16:1(9Z)/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(0:0/16:1(9Z)/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/16:1(9Z)/0:0) is made up of one 9Z-hexadecenoyl(R2).

   

Avocadene 2-acetate

1,4-dihydroxyheptadec-16-en-2-yl acetate

C19H36O4 (328.2613456)


Avocadene 2-acetate is found in fruits. Avocadene 2-acetate is a constituent of avocado (Persea americana) Constituent of avocado (Persea americana). Avocadene 2-acetate is found in fruits.

   

Polyoxyethylene 40 monostearate

17-Hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yl octadecanoate

C20H40O3 (328.297729)


Polyoxyethylene 40 monostearate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials It is used as a food additive .

   

12-hydroxyicosanoic acid

12-hydroxyicosanoic acid

C20H40O3 (328.297729)


12-Hydroxyicosanoic acid is a long-chain hydroxy fatty acid. In humans fatty acids are predominantly formed in the liver and adipose tissue, and mammary glands during lactation.

   

15-hydroxyicosanoic acid

15-Hydroxyeicosanoic acid, (S)-isomer

C20H40O3 (328.297729)


15-Hydroxyicosanoic acid is a long-chain hydroxy fatty acid. In humans fatty acids are predominantly formed in the liver and adipose tissue, and mammary glands during lactation.

   

N-Lauroyl Lysine

6-amino-2-dodecanamidohexanoic acid

C18H36N2O3 (328.2725786)


N-lauroyl lysine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Lysine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Lysine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Lysine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Glyceryl palmitoleate

2,3-Dihydroxypropyl hexadec-9-enoic acid

C19H36O4 (328.2613456)


   

Methyl 8-[3-(2-hydroxyoctyl)oxiran-2-yl]octanoate

Methyl 8-[3-(2-hydroxyoctyl)oxiran-2-yl]octanoic acid

C19H36O4 (328.2613456)


   

12,14-Dihydroxyphytol

(-)-12,14-Dihydroxyphytol

C20H40O3 (328.297729)


   
   

20-Hydroxyeicosanoic acid

20-Hydroxyeicosanoic acid

C20H40O3 (328.297729)


   

Trimethylsilyl palmitoate

Hexadecanic acid, trimethylsilyl ester

C19H40O2Si (328.279742)


   

icos-19-ene-1,2,4-triol

icos-19-ene-1,2,4-triol

C20H40O3 (328.297729)


   

14,16-dinor-plakortide Q

14,16-dinor-plakortide Q

C19H36O4 (328.2613456)


   

Norcon-5-enine, 3.beta.-(methylamino)-

Norcon-5-enine, 3.beta.-(methylamino)-

C22H36N2 (328.2878336)


   

4-Ac-16-Heptadecene-1,2,4-triol

4-Ac-16-Heptadecene-1,2,4-triol

C19H36O4 (328.2613456)


   

methyl 16-acetyloxyhexadecanoate

methyl 16-acetyloxyhexadecanoate

C19H36O4 (328.2613456)


   

2Z-phytene-1,15,20-triol

2Z-phytene-1,15,20-triol

C20H40O3 (328.297729)


   

3alpha-Amino-conanen-(5)

3alpha-Amino-conanen-(5)

C22H36N2 (328.2878336)


   

methyl-9-methoxy-stearate

methyl-9-methoxy-stearate

C20H40O3 (328.297729)


   
   
   

2-hydroxyoctadecyl acetate

2-hydroxyoctadecyl acetate

C20H40O3 (328.297729)


   

Methyl 2-(acetyloxy)hexadecanoate

Methyl 2-(acetyloxy)hexadecanoate

C19H36O4 (328.2613456)


   
   

1-(15-methylhexadec-1-enyloxy)-2,3-propanediol

1-(15-methylhexadec-1-enyloxy)-2,3-propanediol

C20H40O3 (328.297729)


   

18-Methyl-eicosandiol-(1,2)|18-methyl-eicosane-1,2-diol

18-Methyl-eicosandiol-(1,2)|18-methyl-eicosane-1,2-diol

C21H44O2 (328.3341124)


   

2-Ac-16-Heptadecene-1,2,4-triol

2-Ac-16-Heptadecene-1,2,4-triol

C19H36O4 (328.2613456)


   
   
   

(+)-4-hydroxy undecyl nonanoate

(+)-4-hydroxy undecyl nonanoate

C20H40O3 (328.297729)


   

19-nor,14alphaH-cheilantha-13(24),17-diene

19-nor,14alphaH-cheilantha-13(24),17-diene

C24H40 (328.31298400000003)


   
   

20-hydroxyicosanoic acid

20-hydroxyicosanoic acid

C20H40O3 (328.297729)


An omega-hydroxy fatty acid that is icosanoic acid (arachidonic acid) in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.

   

ethyl 3-hydroxyoctadecanoate

ethyl 3-hydroxyoctadecanoate

C20H40O3 (328.297729)


   

1-Ac-16-Heptadecene-1,2,4-triol

1-Ac-16-Heptadecene-1,2,4-triol

C19H36O4 (328.2613456)


   

18-Hydroxyicosanoic acid

18-Hydroxyicosanoic acid

C20H40O3 (328.297729)


   

9,12-DIHYDROXYNONADEC-15-ENOIC ACID

9,12-DIHYDROXYNONADEC-15-ENOIC ACID

C19H36O4 (328.2613456)


   

19-nor,14alphaH-cheilantha-13(24),16-diene

19-nor,14alphaH-cheilantha-13(24),16-diene

C24H40 (328.31298400000003)


   

1,2-heneicosanediol

heneicosane-1,2-diol

C21H44O2 (328.3341124)


   
   

3-heptadecadienylphenol

3-heptadecadienylphenol

C23H36O (328.2766006)


   

4-oxooctyl-2-hydroxyundecanoate

4-oxooctyl-2-hydroxyundecanoate

C19H36O4 (328.2613456)


   

14,18-dinor-plakortide Q

14,18-dinor-plakortide Q

C19H36O4 (328.2613456)


   
   

Henicosane-4,6-diol

Henicosane-4,6-diol

C21H44O2 (328.3341124)


   

1,4-dihydroxyheptadec-16-en-2-yl acetate

NCGC00385642-01!1,4-dihydroxyheptadec-16-en-2-yl acetate

C19H36O4 (328.2613456)


   

1,2-dihydroxyheptadec-16-en-4-yl acetate

NCGC00385126-01!1,2-dihydroxyheptadec-16-en-4-yl acetate

C19H36O4 (328.2613456)


   

2,4-dihydroxyheptadec-16-enyl acetate

NCGC00095546-02!2,4-dihydroxyheptadec-16-enyl acetate

C19H36O4 (328.2613456)


   

Stanozolol

Stanozolol

C21H32N2O (328.25145019999997)


A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid

   

1,2-dihydroxyheptadec-16-en-4-yl acetate

1,2-dihydroxyheptadec-16-en-4-yl acetate

C19H36O4 (328.2613456)


   

2,4-Dihydroxyheptadec-16-enyl acetate

2,4-Dihydroxyheptadec-16-enyl acetate

C19H36O4 (328.2613456)


   

2,4-dihydroxyheptadec-16-enyl acetate [IIN-based on: CCMSLIB00000848387]

NCGC00095546-02!2,4-dihydroxyheptadec-16-enyl acetate [IIN-based on: CCMSLIB00000848387]

C19H36O4 (328.2613456)


   

2,4-dihydroxyheptadec-16-enyl acetate [IIN-based: Match]

NCGC00095546-02!2,4-dihydroxyheptadec-16-enyl acetate [IIN-based: Match]

C19H36O4 (328.2613456)


   

1,4-dihydroxyheptadec-16-en-2-yl acetate [IIN-based: Match]

NCGC00385642-01!1,4-dihydroxyheptadec-16-en-2-yl acetate [IIN-based: Match]

C19H36O4 (328.2613456)


   

1,4-dihydroxyheptadec-16-en-2-yl acetate [IIN-based on: CCMSLIB00000845027]

NCGC00385642-01!1,4-dihydroxyheptadec-16-en-2-yl acetate [IIN-based on: CCMSLIB00000845027]

C19H36O4 (328.2613456)


   

1,2-dihydroxyheptadec-16-en-4-yl acetate_major

1,2-dihydroxyheptadec-16-en-4-yl acetate_major

C19H36O4 (328.2613456)


   

2,4-dihydroxyheptadec-16-enyl acetate_major

2,4-dihydroxyheptadec-16-enyl acetate_major

C19H36O4 (328.2613456)


   

1,2-dihydroxyheptadec-16-en-4-yl acetate_64.3\\%

1,2-dihydroxyheptadec-16-en-4-yl acetate_64.3\\%

C19H36O4 (328.2613456)


   
   
   

3R-hydroxy-eicosanoic acid

Eicosanoic acid, 3-hydroxy-, D-(-)-

C20H40O3 (328.297729)


   

15S-HETE-d8

15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid-d8

C20H24D8O3 (328.285349624)


   

12S-HETE-d8

12S-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoic acid-d8

C20H24D8O3 (328.285349624)


   

(±)11,12-EpETrE-d8

11,12-epoxy-5Z,8Z,14Z-eicosatrienoic acid-d8

C20H24D8O3 (328.285349624)


   

5S-HETE-d8

5S-hydroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (5,6,8,9,11,12,14,15-d8)

C20H24D8O3 (328.285349624)


   

avocadene acetate

2S,4S-dihydroxy-16E-heptadecen-1-yl-acetate

C19H36O4 (328.2613456)


   

13-methylicosane-1,2-diol

13-methyl-1,2-eicosanediol

C21H44O2 (328.3341124)


   

15-methyl-1,2-eicosanediol

15-methyl-1,2-eicosanediol

C21H44O2 (328.3341124)


   

2-Hydroxyphytanic acid

2-hydroxy-3,7,11,15-tetramethylhexadecanoic acid

C20H40O3 (328.297729)


An alpha-hydroxy fatty acid formed from phytanic acid by bacterial cytochrome P450; and also formed in human peroxisomal disorders.

   

MG(16:1)

1-(9Z-hexadecenoyl)-rac-glycerol

C19H36O4 (328.2613456)


   

2-hydroxy-eicosanoic acid

2-hydroxy-eicosanoic acid

C20H40O3 (328.297729)


   

3-hydroxy-eicosanoic acid

3-hydroxy-eicosanoic acid

C20H40O3 (328.297729)


   

20-hydroxy-eicosanoic acid

20-hydroxy-eicosanoic acid

C20H40O3 (328.297729)


   

Avocadene 2-acetate

1,4-dihydroxyheptadec-16-en-2-yl acetate

C19H36O4 (328.2613456)


   

Avocadene 4-acetate

1,2-dihydroxyheptadec-16-en-4-yl acetate

C19H36O4 (328.2613456)


   

1,21-heneicosanediol

1,21-heneicosanediol

C21H44O2 (328.3341124)


   

Ivorit

17-Hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yl octadecanoate

C20H40O3 (328.297729)


D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials

   

erythro-Form

erythro-6,8-Heneicosanediol

C21H44O2 (328.3341124)


   

20:1(9Z)(20F)

20-fluoro-9Z-eicosenoic acid

C20H37FO2 (328.27774339999996)


   

20:1(11Z)(20F)

20-fluoro-11Z-eicosenoic acid

C20H37FO2 (328.27774339999996)


   

FA 20:0;O

Eicosanoic acid, 3-hydroxy-, D-(-)-

C20H40O3 (328.297729)


   

FA 19:1;O2

Nonadecane-1,19-dioic acid

C19H36O4 (328.2613456)


   

(+/-)14,15-EpETrE-(d8)

14,15-epoxy-5Z,8Z,11Z-eicosatrienoic acid-(d8)

C20H24D8O3 (328.285349624)


   

(+/-)8,9-EpETrE-(d8)

8,9-epoxy-5Z,11Z,14Z-eicosatrienoic acid-(d8)

C20H24D8O3 (328.285349624)


   

(+/-)11,12-EpETrE-d8

11,12-epoxy-5Z,8Z,14Z-eicosatrienoic acid-d8

C20H24D8O3 (328.285349624)


   

FOH 21:0;O

15-methyl-1,2-eicosanediol

C21H44O2 (328.3341124)


   

FOH 19:2;O3

1,2-dihydroxyheptadec-16-en-4-yl acetate

C19H36O4 (328.2613456)


   

N-lauroyl lysine

(S)-6-Amino-2-dodecanamidohexanoic acid

C18H36N2O3 (328.2725786)


   

N6-lauroyl lysine

(2S)-2-amino-6-(dodecanoylamino) hexanoic acid

C18H36N2O3 (328.2725786)


   

L-2-Hydroxyphytanate

(2S)-2-hydroxy-3,7,11,15-tetramethylhexadecanoic acid

C20H40O3 (328.297729)


   

3-[[3-(dodecylamino)propyl]amino]butyric acid

3-[[3-(dodecylamino)propyl]amino]butyric acid

C19H40N2O2 (328.308962)


   

12-hydroxystearic acid ethyl ester

12-hydroxystearic acid ethyl ester

C20H40O3 (328.297729)


   

Glyceryl palmitoleate

1-Palmitoleoyl glycerol

C19H36O4 (328.2613456)


   

PPG-2 MYRISTYL ETHER PROPIONATE

PPG-2 MYRISTYL ETHER PROPIONATE

C20H40O3 (328.297729)


   

N2-Dodecanoyl-L-lysine

N2-Dodecanoyl-L-lysine

C18H36N2O3 (328.2725786)


   

2-(3-aminophenyl)quinoline-4-carboxylic acid

2-(3-aminophenyl)quinoline-4-carboxylic acid

C19H36O4 (328.2613456)


   
   

propylene di(octanoate)

propylene di(octanoate)

C19H36O4 (328.2613456)


   

Nonadecanedioic acid

Nonadecanedioic acid

C19H36O4 (328.2613456)


   

1,2-/1,4-dimethyladamantane

1,2-/1,4-dimethyladamantane

C24H40 (328.31298400000003)


   

N-[3-(dimethylamino)propyl]myristamide N-oxide

N-[3-(dimethylamino)propyl]myristamide N-oxide

C19H40N2O2 (328.308962)


   

2-butyl-3,5-(and 3,6)-dimethyl pyrazine

2-butyl-3,5-(and 3,6)-dimethyl pyrazine

C20H32N4 (328.26268319999997)


   

2-hexadecyl-malonic acid

2-hexadecyl-malonic acid

C19H36O4 (328.2613456)


   
   

C20 3-dehydrosphinganine(1+)

C20 3-dehydrosphinganine(1+)

C20H42NO2+ (328.3215372)


   

N2-(1-Oxododecyl)-L-lysine

N2-(1-Oxododecyl)-L-lysine

C18H36N2O3 (328.2725786)


   

Palmitic acid, 4-hydroxybutyl ester

Palmitic acid, 4-hydroxybutyl ester

C20H40O3 (328.297729)


   

Palmitoyllactic acid

Palmitoyllactic acid

C19H36O4 (328.2613456)


   

Methyl 3-(acetyloxy)hexadecanoate

Methyl 3-(acetyloxy)hexadecanoate

C19H36O4 (328.2613456)


   

Polyoxyethylene stearate

Ethylene glycol monostearate

C20H40O3 (328.297729)


D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials

   

omega-Hydroxyphytanic acid

omega-Hydroxyphytanic acid

C20H40O3 (328.297729)


A hydroxy fatty acid obtained by hydroxylation of one of the two terminal methyl groups of phytanic acid.

   

N-(3-Hydroxyhexadecanoyl)glycine

N-(3-Hydroxyhexadecanoyl)glycine

C18H34NO4- (328.2487704)


   

(2R,3S)-3-hydroxy-2-octyldodecanoic acid

(2R,3S)-3-hydroxy-2-octyldodecanoic acid

C20H40O3 (328.297729)


   

[3-carboxy-2-[(E)-undec-4-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-4-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2487704)


   

9-Hexadecenoic acid 2,3-dihydroxypropyl ester

9-Hexadecenoic acid 2,3-dihydroxypropyl ester

C19H36O4 (328.2613456)


   

(3-Carboxy-2-undec-10-enoyloxypropyl)-trimethylazanium

(3-Carboxy-2-undec-10-enoyloxypropyl)-trimethylazanium

C18H34NO4+ (328.2487704)


   

[3-carboxy-2-[(E)-undec-6-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-6-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2487704)


   

[3-carboxy-2-[(E)-undec-2-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-2-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2487704)


   

[3-carboxy-2-[(E)-undec-5-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-5-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2487704)


   

[3-carboxy-2-[(E)-undec-7-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-7-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2487704)


   

[3-carboxy-2-[(E)-undec-3-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-3-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2487704)


   

[3-carboxy-2-[(E)-undec-9-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-9-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2487704)


   

[3-carboxy-2-[(E)-undec-8-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-8-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2487704)


   

[(E)-2-(carboxymethyl)-2-hydroxy-3-oxotridec-4-enyl]-trimethylazanium

[(E)-2-(carboxymethyl)-2-hydroxy-3-oxotridec-4-enyl]-trimethylazanium

C18H34NO4+ (328.2487704)


   
   

19-Hydroxyicosanoic acid

19-Hydroxyicosanoic acid

C20H40O3 (328.297729)


   

N,N-dimethylsphingosine(1+)

N,N-dimethylsphingosine(1+)

C20H42NO2+ (328.3215372)


A sphingoid base(1+) that is the conjugate acid of N,N-dimethylsphingosine, obtained by protonation of the primary amino group; major species at pH 7.3.

   

C20 sphingosine(1+)

C20 sphingosine(1+)

C20H42NO2+ (328.3215372)


A cationic sphingoid that is the conjugate acid of C20 sphingosine, obtained by protonation of the primary amino function; major species at pH 7.3.

   

(19R)-19-hydroxyicosanoic acid

(19R)-19-hydroxyicosanoic acid

C20H40O3 (328.297729)


An (omega-1)-hydroxy fatty acid that is arachidic acid acid in which the 19-pro-R hydrogen is replaced by a hydroxy group.

   

(2S)-hydroxy(palmitoylamino)acetate

(2S)-hydroxy(palmitoylamino)acetate

C18H34NO4- (328.2487704)


   

(1R,2S,10S,13R,14R,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol

(1R,2S,10S,13R,14R,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol

C21H32N2O (328.25145019999997)


   

N-[(5S)-5-(hexanoylamino)-6-hydroxyhexyl]hexanamide

N-[(5S)-5-(hexanoylamino)-6-hydroxyhexyl]hexanamide

C18H36N2O3 (328.2725786)


   

Hexadecanoic acid, trimethylsilyl ester

Hexadecanoic acid, trimethylsilyl ester

C19H40O2Si (328.279742)


   

Pimelic acid, di(hexyl) ester

Pimelic acid, di(hexyl) ester

C19H36O4 (328.2613456)


   

Undecanedioic acid dibutyl ester

Undecanedioic acid dibutyl ester

C19H36O4 (328.2613456)


   

2-Methylpentadecanoic acid trimethylsilyl ester

2-Methylpentadecanoic acid trimethylsilyl ester

C19H40O2Si (328.279742)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] acetate

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] acetate

C19H36O4 (328.2613456)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] propanoate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] propanoate

C19H36O4 (328.2613456)


   

[(2S)-2,3-dihydroxypropyl] (E)-hexadec-9-enoate

[(2S)-2,3-dihydroxypropyl] (E)-hexadec-9-enoate

C19H36O4 (328.2613456)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Isopalmitic acid trimethylsilyl

Isopalmitic acid trimethylsilyl

C19H40O2Si (328.279742)


   

2-Heptadecanoyloxyacetic acid

2-Heptadecanoyloxyacetic acid

C19H36O4 (328.2613456)


   

(1S,2S,10S,13R,14S,17S,18R)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol

(1S,2S,10S,13R,14S,17S,18R)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol

C21H32N2O (328.25145019999997)


   

[(2S)-2,3-dihydroxypropyl] (E)-hexadec-7-enoate

[(2S)-2,3-dihydroxypropyl] (E)-hexadec-7-enoate

C19H36O4 (328.2613456)


   

(2S)-2-hydroxyphytanic acid

(2S)-2-hydroxyphytanic acid

C20H40O3 (328.297729)


A 20-carbon, methyl-branched hydroxy fatty acid and intermediate in phytanic acid degradation; accumulates in patients with peroxisimal disorders.

   

Avocadene 1-acetate

Avocadene 1-acetate

C19H36O4 (328.2613456)


   

2-[(9Z)-hexadecenoyl]glycerol

2-[(9Z)-hexadecenoyl]glycerol

C19H36O4 (328.2613456)


A monoacylglycerol 16:1 in which the acyl group specified at position 2 is 9Z)-hexadecenoyl.

   

2-hydroxyarachidic acid

2-hydroxyarachidic acid

C20H40O3 (328.297729)


A long-chain fatty acid that is arachidic (icosanoic) acid substituted at position 2 by a hydroxy group.

   

3-hydroxyicosanoic acid

3-hydroxyicosanoic acid

C20H40O3 (328.297729)


A long-chain fatty acid that is icosanoic acid carrying a 3-hydroxy substituent.

   

erythro-6,8-Heneicosanediol

erythro-6,8-Heneicosanediol

C21H44O2 (328.3341124)


   

15-hydroxyicosanoic acid

15-hydroxyicosanoic acid

C20H40O3 (328.297729)


   

12-hydroxyicosanoic acid

12-hydroxyicosanoic acid

C20H40O3 (328.297729)


   

11-methoxynonadecanoic acid

11-methoxynonadecanoic acid

C20H40O3 (328.297729)


   
   

monoacylglycerol 16:1

monoacylglycerol 16:1

C19H36O4 (328.2613456)


A monoglyceride in which the acyl group contains a total of 16 carbon atoms and 1 double bond.

   

2-acylglycerol 16:1

2-acylglycerol 16:1

C19H36O4 (328.2613456)


A 2-monoglyceride in which the acyl group contains 16 carbons and 1 double bond.

   

DG(16:1)

DG(10:1(1)_6:0)

C19H36O4 (328.2613456)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hydroxyeicosanoic acid

Hydroxyeicosanoic acid

C20H40O3 (328.297729)


   
   
   
   

FAHFA 10:0/3O-9:0

FAHFA 10:0/3O-9:0

C19H36O4 (328.2613456)


   
   

FAHFA 11:0/3O-8:0

FAHFA 11:0/3O-8:0

C19H36O4 (328.2613456)


   
   

FAHFA 13:0/3O-6:0

FAHFA 13:0/3O-6:0

C19H36O4 (328.2613456)


   
   

FAHFA 4:0/15O-15:0

FAHFA 4:0/15O-15:0

C19H36O4 (328.2613456)


   

FAHFA 5:0/2O-14:0

FAHFA 5:0/2O-14:0

C19H36O4 (328.2613456)


   

FAHFA 6:0/3O-13:0

FAHFA 6:0/3O-13:0

C19H36O4 (328.2613456)


   

FAHFA 7:0/3O-12:0

FAHFA 7:0/3O-12:0

C19H36O4 (328.2613456)


   

FAHFA 8:0/3O-11:0

FAHFA 8:0/3O-11:0

C19H36O4 (328.2613456)


   
   

FAHFA 9:0/3O-10:0

FAHFA 9:0/3O-10:0

C19H36O4 (328.2613456)


   
   

MG 0:0/16:1(9Z)/0:0

MG 0:0/16:1(9Z)/0:0

C19H36O4 (328.2613456)


   
   

MG 16:1(9Z)/0:0/0:0

MG 16:1(9Z)/0:0/0:0

C19H36O4 (328.2613456)


   

Hydroxyphytanic acid

Hydroxyphytanic acid

C20H40O3 (328.297729)


   
   

(2r,4r)-2,4-dihydroxyheptadec-16-en-1-yl acetate

(2r,4r)-2,4-dihydroxyheptadec-16-en-1-yl acetate

C19H36O4 (328.2613456)


   

(4e)-1-[(2s)-2,3-dihydroxypropoxy]hexadec-4-en-6-one

(4e)-1-[(2s)-2,3-dihydroxypropoxy]hexadec-4-en-6-one

C19H36O4 (328.2613456)


   

2z-phytene-1,15,20-triol

NA

C20H40O3 (328.297729)


{"Ingredient_id": "HBIN006868","Ingredient_name": "2z-phytene-1,15,20-triol","Alias": "NA","Ingredient_formula": "C20H40O3","Ingredient_Smile": "CC(CCCC(C)CCCC(C)(C)O)CCCC(=CCO)CO","Ingredient_weight": "328.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "17241","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "12080816","DrugBank_id": "NA"}

   

3-epicaonamine

NA

C22H36N2 (328.2878336)


{"Ingredient_id": "HBIN008471","Ingredient_name": "3-epicaonamine","Alias": "NA","Ingredient_formula": "C22H36N2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25801","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-epiconamine

NA

C22H36N2 (328.2878336)


{"Ingredient_id": "HBIN008472","Ingredient_name": "3-epiconamine","Alias": "NA","Ingredient_formula": "C22H36N2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6872","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

9,12-dihydroxy-15-nonadecenoic acid

9,12-dihydroxy-15-nonadecenoicacid

C19H36O4 (328.2613456)


{"Ingredient_id": "HBIN013990","Ingredient_name": "9,12-dihydroxy-15-nonadecenoic acid","Alias": "9,12-dihydroxy-15-nonadecenoicacid","Ingredient_formula": "C19H36O4","Ingredient_Smile": "CCCC=CCCC(CCC(CCCCCCCC(=O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25887;6046","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-[(15-methylhexadec-1-en-1-yl)oxy]propane-1,2-diol

3-[(15-methylhexadec-1-en-1-yl)oxy]propane-1,2-diol

C20H40O3 (328.297729)


   

(2s)-6-amino-2-[(1-hydroxydodecylidene)amino]hexanoic acid

(2s)-6-amino-2-[(1-hydroxydodecylidene)amino]hexanoic acid

C18H36N2O3 (328.2725786)


   

undecyl 4-hydroxynonanoate

undecyl 4-hydroxynonanoate

C20H40O3 (328.297729)


   

6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-16-amine

6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-16-amine

C22H36N2 (328.2878336)


   

(2e,7r,11s,12s,14r)-3,7,11,15-tetramethylhexadec-2-ene-1,12,14-triol

(2e,7r,11s,12s,14r)-3,7,11,15-tetramethylhexadec-2-ene-1,12,14-triol

C20H40O3 (328.297729)


   

(2s,4s)-2,4-dihydroxyheptadec-16-en-1-yl acetate

(2s,4s)-2,4-dihydroxyheptadec-16-en-1-yl acetate

C19H36O4 (328.2613456)


   

1-{4-decyltetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-en-8-yl}ethanone

1-{4-decyltetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-en-8-yl}ethanone

C23H36O (328.2766006)


   

(2r)-2,3-dihydroxypropyl (9z)-hexadec-9-enoate

(2r)-2,3-dihydroxypropyl (9z)-hexadec-9-enoate

C19H36O4 (328.2613456)


   

(2s)-3-{[(1z)-15-methylhexadec-1-en-1-yl]oxy}propane-1,2-diol

(2s)-3-{[(1z)-15-methylhexadec-1-en-1-yl]oxy}propane-1,2-diol

C20H40O3 (328.297729)


   

1-(2,3-dihydroxypropoxy)hexadec-4-en-6-one

1-(2,3-dihydroxypropoxy)hexadec-4-en-6-one

C19H36O4 (328.2613456)


   

(2r)-2,3-dihydroxypropyl hexadec-9-enoate

(2r)-2,3-dihydroxypropyl hexadec-9-enoate

C19H36O4 (328.2613456)


   

(6e)-1-[(2s)-2,3-dihydroxypropoxy]hexadec-6-en-5-one

(6e)-1-[(2s)-2,3-dihydroxypropoxy]hexadec-6-en-5-one

C19H36O4 (328.2613456)


   

methyl 2-[(3r,4s,6s)-4,6-diethyl-6-[(2s)-2-ethylhexyl]-1,2-dioxan-3-yl]acetate

methyl 2-[(3r,4s,6s)-4,6-diethyl-6-[(2s)-2-ethylhexyl]-1,2-dioxan-3-yl]acetate

C19H36O4 (328.2613456)


   

(6r,8s)-henicosane-6,8-diol

(6r,8s)-henicosane-6,8-diol

C21H44O2 (328.3341124)


   

(5e,7r,9e,13e)-2,6,10-trimethyl-7-[(3r)-3-methylpent-4-en-1-yl]pentadeca-2,5,9,13-tetraene

(5e,7r,9e,13e)-2,6,10-trimethyl-7-[(3r)-3-methylpent-4-en-1-yl]pentadeca-2,5,9,13-tetraene

C24H40 (328.31298400000003)


   

undecyl (4r)-4-hydroxynonanoate

undecyl (4r)-4-hydroxynonanoate

C20H40O3 (328.297729)


   

methyl 2-[(3s,4s,6s)-4,6-diethyl-6-[(2s)-2-ethylhexyl]-1,2-dioxan-3-yl]acetate

methyl 2-[(3s,4s,6s)-4,6-diethyl-6-[(2s)-2-ethylhexyl]-1,2-dioxan-3-yl]acetate

C19H36O4 (328.2613456)


   

1-(2,3-dihydroxypropoxy)hexadec-6-en-5-one

1-(2,3-dihydroxypropoxy)hexadec-6-en-5-one

C19H36O4 (328.2613456)


   

3-(heptadeca-1,3-dien-1-yl)phenol

3-(heptadeca-1,3-dien-1-yl)phenol

C23H36O (328.2766006)


   

1-[(1s,2s,3s,4r,5s,7s,8r)-4-decyltetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-en-8-yl]ethanone

1-[(1s,2s,3s,4r,5s,7s,8r)-4-decyltetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-en-8-yl]ethanone

C23H36O (328.2766006)


   

1-[(1s,2s,3s,4r,5s,7s,8r,9r)-4-decyltetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-en-8-yl]ethanone

1-[(1s,2s,3s,4r,5s,7s,8r,9r)-4-decyltetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-en-8-yl]ethanone

C23H36O (328.2766006)


   

(2s)-2-amino-6-[(1-hydroxydodecylidene)amino]hexanoic acid

(2s)-2-amino-6-[(1-hydroxydodecylidene)amino]hexanoic acid

C18H36N2O3 (328.2725786)


   

3,7,11,15-tetramethylhexadec-2-ene-1,12,14-triol

3,7,11,15-tetramethylhexadec-2-ene-1,12,14-triol

C20H40O3 (328.297729)


   

(1s,2r,5s,6r,9r,12s,13s,16r)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-16-amine

(1s,2r,5s,6r,9r,12s,13s,16r)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-16-amine

C22H36N2 (328.2878336)


   

4-oxooctyl (2r)-2-hydroxyundecanoate

4-oxooctyl (2r)-2-hydroxyundecanoate

C19H36O4 (328.2613456)


   

(2r,4r)-1,2-dihydroxyheptadec-16-en-4-yl acetate

(2r,4r)-1,2-dihydroxyheptadec-16-en-4-yl acetate

C19H36O4 (328.2613456)


   

2,6,10-trimethyl-7-(3-methylpent-4-en-1-yl)pentadeca-2,5,9,13-tetraene

2,6,10-trimethyl-7-(3-methylpent-4-en-1-yl)pentadeca-2,5,9,13-tetraene

C24H40 (328.31298400000003)


   

4-oxooctyl 2-hydroxyundecanoate

4-oxooctyl 2-hydroxyundecanoate

C19H36O4 (328.2613456)